GSRLX
Price
$13.28
Change
+$0.17 (+1.30%)
Updated
Sep 11 closing price
Net Assets
401.73M
VFINX
Price
$708.03
Change
+$6.07 (+0.86%)
Updated
Sep 11 closing price
Net Assets
1.76T
Interact to see
Advertisement

GSRLX vs VFINX

GSRLX vs VFINX Comparison Chart in %
View a ticker or compare two or three
VS
GSRLX vs. VFINX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSRLX is a Buy and VFINX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.76T vs. GSRLX (402M). GSRLX pays higher dividends than VFINX: GSRLX (1.36) vs VFINX (0.94). GSRLX was incepted earlier than VFINX: GSRLX (19 years) vs VFINX (50 years). GSRLX (0.93) is less costly to investors than VFINX (0.14). GSRLX is a more actively managed with annual turnover of: 35.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than GSRLX: VFINX (0) vs GSRLX (1000000). VFINX annual gain was more profitable for investors over the last year : 15.25 vs. GSRLX (1.53). VFINX return over 5 years is better than : 70.38 vs. GSRLX (1.66).
GSRLXVFINXGSRLX / VFINX
Total Expense Ratio0.690.14493%
Annual Report Gross Expense Ratio0.930.14664%
Fund Existence19 years50 years-
Gain YTD12.35811.097111%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets402M1.76T0%
Annual Yield % from dividends1.360.94145%
Returns for 1 year1.5315.2510%
Returns for 3 years14.9370.2421%
Returns for 5 years1.6670.382%
Returns for 10 years-21.90258.28-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGRX1.680.25
+17.48%
Sangrix Inc.
CLOV4.820.11
+2.34%
Clover Health Investments Corp
WKEY6.360.06
+0.95%
WISeKey International Holding Ltd
JBS12.59-0.03
-0.24%
JBS NV Ordinary Shares - Class A
IRD6.04-0.03
-0.49%
Opus Genetics Inc